apomorphine has been researched along with naxagolide in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 6 (42.86) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dijkstra, D; Horn, AS; Mulder, TB; Rollema, H; Tepper, PG; Van der Weide, J | 1 |
Diederich, NJ; Goetz, CG | 1 |
Lawrence, MS; Redmond, DE | 1 |
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ | 1 |
Barth, TM; Dourish, CT; Iversen, SD; Martin-Iverson, MT; Stoessl, AJ | 1 |
Jones, JH; Lotti, VJ; Martin, GE; Pettibone, DJ; Taylor, DA; Williams, M; Zrada, MM | 1 |
Czuczwar, SJ; Löscher, W | 1 |
Clineschmidt, BV; Jones, JH; Martin, GE; Pettibone, DJ; Williams, M; Yarbrough, GG | 1 |
Herrero, MT; Laguna, J; Luquin, MR; Obeso, JA | 1 |
Day, J; Fibiger, HC | 1 |
Ashmeade, T; Routledge, C; Taylor, S; Thorn, L | 1 |
Else, D; Martin-Iverson, MT | 1 |
Seeman, P | 1 |
Ding, M; Dorff, P; Elmore, CS; Maier, D; Malmquist, J; Mrzljak, L; Peng, T; Ström, P; Tuke, D; Werkheiser, J; Widzowski, D; Zysk, J | 1 |
1 review(s) available for apomorphine and naxagolide
Article | Year |
---|---|
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
13 other study(ies) available for apomorphine and naxagolide
Article | Year |
---|---|
Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation.
Topics: Animals; Benzopyrans; Binding Sites; Brain Chemistry; Cattle; Dopamine; Dopamine Agents; Nitrogen; Oxazines; Protons; Rats; Receptors, Dopamine | 1988 |
MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poisoning; Oxazines; Parkinson Disease; Receptors, Dopamine; Substantia Nigra; Sulpiride | 1991 |
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxazines; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1990 |
Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
Topics: Aging; Animals; Apomorphine; Dopamine Agents; Male; Motor Activity; Oxazines; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1989 |
Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
Topics: Animals; Apomorphine; Cats; Clonidine; Ergolines; In Vitro Techniques; Lisuride; Male; Muscle Contraction; Mydriatics; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Vas Deferens | 1985 |
Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy.
Topics: Animals; Anticonvulsants; Apomorphine; Female; Gerbillinae; Kindling, Neurologic; Levodopa; Lisuride; Male; Mice; Oxazines; Rats; Receptors, Dopamine; Stimulation, Chemical | 1986 |
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
Topics: Adenylyl Cyclases; Animals; Apomorphine; Binding, Competitive; Body Temperature; Brain Stem; Female; Fishes; Humans; Hydroxydopamines; Mice; Motor Activity; Oxazines; Oxidopamine; Posture; Rats; Rats, Inbred Strains; Receptors, Dopamine; Retina; Spiperone; Stereotyped Behavior; Vomiting | 1984 |
Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agents; Drug Tolerance; Female; Macaca fascicularis; Male; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Psychomotor Performance | 1993 |
Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists.
Topics: Acetylcholine; Animals; Apomorphine; Benzazepines; Cerebral Cortex; Dialysis; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Indoles; Male; Nerve Endings; Oxazines; Phenanthridines; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1993 |
Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Ergolines; Male; Mice; Mice, Inbred Strains; Microdialysis; Neurons; Nucleus Accumbens; Oxazines; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 1996 |
PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats.
Topics: Analysis of Variance; Animals; Apomorphine; Dopamine Agonists; Male; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reflex, Startle | 2000 |
Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Binding, Competitive; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Statistics as Topic; Tritium | 2007 |
D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Topics: Animals; Apomorphine; Binding Sites; Binding, Competitive; Brain; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Oxazines; Raclopride; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, G-Protein-Coupled | 2010 |